Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

Archive ouverte

de Boysson, Hubert | Devauchelle-Pensec, Valérie | Agard, Christian | André, Marc | Bienvenu, Boris | Bonnotte, Bernard | Carvajal Alegria, Guillermo | Espitia, Olivier | Hachulla, Eric | Héron, Emmanuel | Lambert, Marc | Lega, Jean-Christophe | Ly, Kim | Mekinian, Arsène | Morel, Jacques | Régent, Alexis | Richez, Christophe | Sailler, Laurent | Seror, Raphaele | Tournadre, Anne | Samson, Maxime

Edité par CCSD ; Elsevier -

International audience. An updated revision of the 2016 recommendations from the French Study Group for Large Vessel Vasculitis (GEFA) was needed to better delineate the place and management of immunosuppressants or biologics in giant cell arteritis (GCA).

Consulter en ligne

Suggestions

Du même auteur

Polyarteritis Nodosa Neurologic Manifestations

Archive ouverte | de Boysson, Hubert | CCSD

International audience

French protocol for the diagnosis and management of giant cell arteritis

Archive ouverte | de Boysson, Hubert | CCSD

International audience. Giant cell arteritis (GCA) is a large-vessel vasculitis that mainly affects women over fifty. GCA usually involves branches from the external carotid arteries, causing symptoms such as headac...

An overview of the perspectives on experimental models and new therapeutic targets in giant cell arteritis

Archive ouverte | Deshayes, Samuel | CCSD

International audience

Chargement des enrichissements...